Barber Cooper, Syski Andrew, Leaird Jennifer, Call R Christopher, Williams Ann, Learn Peter
Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Mil Med. 2023 Jul 22;188(7-8). doi: 10.1093/milmed/usab522. Epub 2021 Dec 11.
Facing the COVID-19 pandemic, many hospitals implemented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening protocols before aerosol-generating procedures (AGPs) in an effort to protect patients and health care workers. Given the limited prior evidence on the effectiveness of such protocols, we report the process improvement experience at a military treatment facility.
We evaluated the outcomes of patients undergoing AGPs from March to September 2020, divided into three cohorts: a preprotocol (PP) cohort who did not receive screening, an early testing (ET) cohort representing the early months of the screening protocol, and a late testing (LT) cohort managed under adaptive modifications to the screening protocol. We recorded identifiable post-procedure COVID-19 diagnoses. The study was approved as a process improvement protocol and was determined not to meet criteria for human subject research through an institutional approval process.
Across the three cohorts, 4520 procedures were performed: 422 PP, 1297 ET, and 2801 LT. Among 4098 procedures in the ET and LT cohorts, 12 asymptomatic patients tested positive for SARS-CoV-2 (0.29% positivity rate). One left the health system before completing the procedure and another proceeded urgently under COVID precautions, while 10 were rescheduled and completed at a later date; 7 were cleared using a test-based strategy, while 3 were cleared using a time-based strategy. Of 445 patients who had SARS-CoV-2 tests performed within 30 days following their procedures, three patients with negative preoperative tests had a positive test within 30 days, all in the LT cohort but had evidence of acquiring the infection after the procedure or had a false-positive test.
Our strategy of preprocedural SARS-CoV-2 testing successfully identified asymptomatic infected patients before surgery. Care was delayed for most of these patients without apparent detriment. Adaptation to a time-based strategy for clearance might reduce such delays, but other considerations may still influence how soon procedures should be completed after a positive test.
面对新冠疫情,许多医院在实施产生气溶胶的操作(AGP)之前,都执行了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)筛查方案,以保护患者和医护人员。鉴于此前关于此类方案有效性的证据有限,我们报告一家军队治疗机构的流程改进经验。
我们评估了2020年3月至9月接受AGP的患者的结果,分为三个队列:未接受筛查的预方案(PP)队列、代表筛查方案早期几个月的早期检测(ET)队列,以及在对筛查方案进行适应性修改下管理的晚期检测(LT)队列。我们记录了术后可识别的新冠诊断情况。该研究作为一项流程改进方案获得批准,并通过机构审批程序确定不符合人体研究标准。
在这三个队列中,共进行了4520例操作:422例PP、1297例ET和2801例LT。在ET和LT队列的4098例操作中,12例无症状患者的SARS-CoV-2检测呈阳性(阳性率为0.29%)。1例在完成操作前离开了医疗系统,另1例在新冠预防措施下紧急进行了操作,而10例被重新安排并在之后完成;7例通过基于检测的策略被清除,3例通过基于时间的策略被清除。在术后30天内进行SARS-CoV-2检测的445例患者中,3例术前检测为阴性的患者在30天内检测呈阳性,均在LT队列中,但有证据表明是在术后感染或检测为假阳性。
我们术前进行SARS-CoV-2检测的策略成功地在手术前识别出无症状感染患者。这些患者中的大多数护理被推迟,但没有明显的不良影响。采用基于时间的清除策略可能会减少此类延迟,但其他因素仍可能影响检测呈阳性后手术应尽快完成的时间。